Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Other financing activities (2017 - 2026)

Sensus Healthcare has reported Other financing activities over the past 9 years, most recently at $76000.0 for Q4 2025.

  • For Q4 2025, Other financing activities fell 37.7% year-over-year to $76000.0; the TTM value through Dec 2025 reached $300000.0, down 7.69%, while the annual FY2025 figure was $300000.0, 7.69% down from the prior year.
  • Other financing activities for Q4 2025 was $76000.0 at Sensus Healthcare, up from $73000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $206000.0 in Q3 2021 and troughed at -$57000.0 in Q3 2022.
  • A 5-year average of $79800.0 and a median of $69500.0 in 2023 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: skyrocketed 456.76% in 2021 and later plummeted 127.67% in 2022.
  • Year by year, Other financing activities stood at $90000.0 in 2021, then soared by 74.44% to $157000.0 in 2022, then crashed by 59.24% to $64000.0 in 2023, then surged by 90.62% to $122000.0 in 2024, then crashed by 37.7% to $76000.0 in 2025.
  • Business Quant data shows Other financing activities for SRTS at $76000.0 in Q4 2025, $73000.0 in Q3 2025, and $72000.0 in Q2 2025.